1. Short Arrestin-3-Derived Peptides Activate JNK3 in Cells.
- Author
-
Perry-Hauser NA, Kaoud TS, Stoy H, Zhan X, Chen Q, Dalby KN, Iverson TM, Gurevich VV, and Gurevich EV
- Subjects
- Arrestins metabolism, Peptides metabolism, Peptides pharmacology, Phosphorylation physiology, Protein Binding physiology, beta-Arrestin 2 metabolism, beta-Arrestins metabolism, Arrestin metabolism, Mitogen-Activated Protein Kinase 10 metabolism
- Abstract
Arrestins were first discovered as suppressors of G protein-mediated signaling by G protein-coupled receptors. It was later demonstrated that arrestins also initiate several signaling branches, including mitogen-activated protein kinase cascades. Arrestin-3-dependent activation of the JNK family can be recapitulated with peptide fragments, which are monofunctional elements distilled from this multi-functional arrestin protein. Here, we use maltose-binding protein fusions of arrestin-3-derived peptides to identify arrestin elements that bind kinases of the ASK1-MKK4/7-JNK3 cascade and the shortest peptide facilitating JNK signaling. We identified a 16-residue arrestin-3-derived peptide expressed as a Venus fusion that leads to activation of JNK3α2 in cells. The strength of the binding to the kinases does not correlate with peptide activity. The ASK1-MKK4/7-JNK3 cascade has been implicated in neuronal apoptosis. While inhibitors of MAP kinases exist, short peptides are the first small molecule tools that can activate MAP kinases.
- Published
- 2022
- Full Text
- View/download PDF